H Schönenberger Selected Research

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)

10/2001	Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.
12/2000	Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Schönenberger Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 10/2001 - 03/2000
5	Neoplasms (Cancer) 10/2001 - 11/2000

Drug/Important Bio-Agent (IBA)

5	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 10/2001 - 03/2000
4	Hormones (Hormone)IBA 04/2001 - 03/2000
3	PlatinumIBA 10/2001 - 11/2000
3	Immunologic Factors (Immunomodulators)IBA 04/2001 - 03/2000
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2001 - 12/2000
2	DNA (Deoxyribonucleic Acid)IBA 10/2001 - 11/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2001 - 12/2000
2	Estrogens (Estrogen)FDA Link 04/2001 - 11/2000
1	(meso- 1,2- bis- (2,6- dichloro- 4- hydroxyphenyl)ethylenediamine)dichloroplatinum(II)IBA 10/2001
1	Estrogen ReceptorsIBA 10/2001
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2000
1	Cisplatin (Platino)FDA LinkGeneric 11/2000
1	ThymidineIBA 11/2000
1	ovexIBA 11/2000

Therapy/Procedure

1	Therapeutics 04/2001
1	Splenectomy 12/2000